Saba Capital Management’s CERo Therapeutics CERO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-606
| Closed | -$12.4M | – | 778 |
|
|
2022
Q4 | $12.4M | Hold |
606
| – | – | 0.17% | 180 |
|
|
2022
Q3 | $12.2M | Buy |
606
+40
| +7% | +$807K | 0.14% | 246 |
|
|
2022
Q2 | $11.3M | Buy |
566
+199
| +54% | +$3.99M | 0.13% | 248 |
|
|
2022
Q1 | $7.34M | Buy |
367
+47
| +15% | +$940K | 0.1% | 330 |
|
|
2021
Q4 | $6.34M | Buy |
+320
| New | +$6.34M | 0.1% | 298 |
|